Balrampur Chini Mills Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 9:18 pm

Quick Insight

Balrampur Chini Mills Ltd, with a current share price of 548 and a market capitalization of 11,079 Cr., is trading at a P/E ratio of 26.5, indicating a moderate valuation. The company's ROE stands at 11.0% and ROCE at 10.2%, reflecting decent profitability and capital efficiency. With a healthy operating profit margin of 24% and a net profit of 437 Cr., Balrampur Chini seems to be managing its operations effectively. The company's shareholder distribution includes significant holdings by promoters (42.89%), FIIs (12.19%), and DIIs (22.58%). Additionally, the firm's P/BV ratio of 2.15x and ICR of 11.55x suggest a balanced financial position. However, the substantial borrowing of ₹2,627 Cr. warrants attention as it could impact the company's leverage and future growth prospects. Overall, investors should keep a close watch on the company's debt levels and operational efficiency to make informed investment decisions.

Competitors of Balrampur Chini Mills Ltd

All Competitor Stocks of Balrampur Chini Mills Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:05 pm

Below is a detailed analysis of the quarterly data for Balrampur Chini Mills Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,542.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,504.00 Cr. (Mar 2025) to 1,542.00 Cr., marking an increase of 38.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,408.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,138.00 Cr. (Mar 2025) to 1,408.00 Cr., marking an increase of 270.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 134.00 Cr.. The value appears to be declining and may need further review. It has decreased from 365.00 Cr. (Mar 2025) to 134.00 Cr., marking a decrease of 231.00 Cr..
• For OPM %, as of Jun 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 24.00% (Mar 2025) to 9.00%, marking a decrease of 15.00%.
• For Other Income, as of Jun 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Mar 2025) to 16.00 Cr., marking a decrease of 4.00 Cr..
• For Interest, as of Jun 2025, the value is 34.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.00 Cr. (Mar 2025) to 34.00 Cr., marking an increase of 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 44.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 43.00 Cr. (Mar 2025) to 44.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 73.00 Cr.. The value appears to be declining and may need further review. It has decreased from 312.00 Cr. (Mar 2025) to 73.00 Cr., marking a decrease of 239.00 Cr..
• For Tax %, as of Jun 2025, the value is 29.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Mar 2025) to 29.00%, marking an increase of 3.00%.
• For Net Profit, as of Jun 2025, the value is 52.00 Cr.. The value appears to be declining and may need further review. It has decreased from 229.00 Cr. (Mar 2025) to 52.00 Cr., marking a decrease of 177.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.55. The value appears to be declining and may need further review. It has decreased from 11.35 (Mar 2025) to 2.55, marking a decrease of 8.80.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:27 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:24 pm

Below is a detailed analysis of the balance sheet data for Balrampur Chini Mills Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 20.00 Cr..
• For Reserves, as of Mar 2025, the value is 3,775.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,381.00 Cr. (Mar 2024) to 3,775.00 Cr., marking an increase of 394.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2,627.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2,009.00 Cr. (Mar 2024) to 2,627.00 Cr., marking an increase of 618.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 707.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 678.00 Cr. (Mar 2024) to 707.00 Cr., marking an increase of 29.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 7,129.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,088.00 Cr. (Mar 2024) to 7,129.00 Cr., marking an increase of 1,041.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 2,645.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,639.00 Cr. (Mar 2024) to 2,645.00 Cr., marking an increase of 6.00 Cr..
• For CWIP, as of Mar 2025, the value is 106.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2024) to 106.00 Cr., marking an increase of 60.00 Cr..
• For Investments, as of Mar 2025, the value is 431.00 Cr.. The value appears strong and on an upward trend. It has increased from 339.00 Cr. (Mar 2024) to 431.00 Cr., marking an increase of 92.00 Cr..
• For Other Assets, as of Mar 2025, the value is 3,947.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,064.00 Cr. (Mar 2024) to 3,947.00 Cr., marking an increase of 883.00 Cr..
• For Total Assets, as of Mar 2025, the value is 7,129.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,088.00 Cr. (Mar 2024) to 7,129.00 Cr., marking an increase of 1,041.00 Cr..

Notably, the Reserves (3,775.00 Cr.) exceed the Borrowings (2,627.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Balrampur Chini Mills Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 26.49. This value is within the healthy range. It has increased from 13.94 (Mar 23) to 26.49, marking an increase of 12.55.
• For Diluted EPS (Rs.), as of Mar 24, the value is 26.49. This value is within the healthy range. It has increased from 13.94 (Mar 23) to 26.49, marking an increase of 12.55.
• For Cash EPS (Rs.), as of Mar 24, the value is 33.44. This value is within the healthy range. It has increased from 19.93 (Mar 23) to 33.44, marking an increase of 13.51.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 168.57. It has increased from 143.52 (Mar 23) to 168.57, marking an increase of 25.05.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 168.57. It has increased from 143.52 (Mar 23) to 168.57, marking an increase of 25.05.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 277.26. It has increased from 231.27 (Mar 23) to 277.26, marking an increase of 45.99.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 47.89. This value is within the healthy range. It has increased from 28.49 (Mar 23) to 47.89, marking an increase of 19.40.
• For PBIT / Share (Rs.), as of Mar 24, the value is 39.64. This value is within the healthy range. It has increased from 22.07 (Mar 23) to 39.64, marking an increase of 17.57.
• For PBT / Share (Rs.), as of Mar 24, the value is 35.50. This value is within the healthy range. It has increased from 19.66 (Mar 23) to 35.50, marking an increase of 15.84.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 25.20. This value is within the healthy range. It has increased from 13.51 (Mar 23) to 25.20, marking an increase of 11.69.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 26.49. This value is within the healthy range. It has increased from 14.09 (Mar 23) to 26.49, marking an increase of 12.40.
• For PBDIT Margin (%), as of Mar 24, the value is 17.27. This value is within the healthy range. It has increased from 12.31 (Mar 23) to 17.27, marking an increase of 4.96.
• For PBIT Margin (%), as of Mar 24, the value is 14.29. This value is within the healthy range. It has increased from 9.54 (Mar 23) to 14.29, marking an increase of 4.75.
• For PBT Margin (%), as of Mar 24, the value is 12.80. This value is within the healthy range. It has increased from 8.50 (Mar 23) to 12.80, marking an increase of 4.30.
• For Net Profit Margin (%), as of Mar 24, the value is 9.08. This value is within the healthy range. It has increased from 5.84 (Mar 23) to 9.08, marking an increase of 3.24.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.55. This value is within the healthy range. It has increased from 6.09 (Mar 23) to 9.55, marking an increase of 3.46.
• For Return on Networth / Equity (%), as of Mar 24, the value is 15.71. This value is within the healthy range. It has increased from 9.81 (Mar 23) to 15.71, marking an increase of 5.90.
• For Return on Capital Employeed (%), as of Mar 24, the value is 20.16. This value is within the healthy range. It has increased from 12.85 (Mar 23) to 20.16, marking an increase of 7.31.
• For Return On Assets (%), as of Mar 24, the value is 8.78. This value is within the healthy range. It has increased from 5.23 (Mar 23) to 8.78, marking an increase of 3.55.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.09. This value is below the healthy minimum of 0.2. It has decreased from 0.14 (Mar 23) to 0.09, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.59. This value is within the healthy range. It has decreased from 0.64 (Mar 23) to 0.59, marking a decrease of 0.05.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.97. It has increased from 0.94 (Mar 23) to 0.97, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 24, the value is 1.43. This value is below the healthy minimum of 1.5. It has increased from 1.31 (Mar 23) to 1.43, marking an increase of 0.12.
• For Quick Ratio (X), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 1. It has decreased from 0.13 (Mar 23) to 0.07, marking a decrease of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.77. This value is below the healthy minimum of 4. It has increased from 1.51 (Mar 23) to 1.77, marking an increase of 0.26.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 11.32. This value is below the healthy minimum of 20. It has decreased from 17.89 (Mar 23) to 11.32, marking a decrease of 6.57.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 8.63. This value is below the healthy minimum of 20. It has decreased from 12.29 (Mar 23) to 8.63, marking a decrease of 3.66.
• For Earning Retention Ratio (%), as of Mar 24, the value is 88.68. This value exceeds the healthy maximum of 70. It has increased from 82.11 (Mar 23) to 88.68, marking an increase of 6.57.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 91.37. This value exceeds the healthy maximum of 70. It has increased from 87.71 (Mar 23) to 91.37, marking an increase of 3.66.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 11.55. This value is within the healthy range. It has decreased from 11.82 (Mar 23) to 11.55, marking a decrease of 0.27.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 7.08. This value is within the healthy range. It has increased from 6.60 (Mar 23) to 7.08, marking an increase of 0.48.
• For Enterprise Value (Cr.), as of Mar 24, the value is 9,300.53. It has decreased from 9,855.99 (Mar 23) to 9,300.53, marking a decrease of 555.46.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.66. This value is within the healthy range. It has decreased from 2.11 (Mar 23) to 1.66, marking a decrease of 0.45.
• For EV / EBITDA (X), as of Mar 24, the value is 9.63. This value is within the healthy range. It has decreased from 17.15 (Mar 23) to 9.63, marking a decrease of 7.52.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has decreased from 1.71 (Mar 23) to 1.30, marking a decrease of 0.41.
• For Retention Ratios (%), as of Mar 24, the value is 88.67. This value exceeds the healthy maximum of 70. It has increased from 82.10 (Mar 23) to 88.67, marking an increase of 6.57.
• For Price / BV (X), as of Mar 24, the value is 2.15. This value is within the healthy range. It has decreased from 2.76 (Mar 23) to 2.15, marking a decrease of 0.61.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has decreased from 1.71 (Mar 23) to 1.30, marking a decrease of 0.41.
• For EarningsYield, as of Mar 24, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 23) to 0.07, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness